Rare Ichthyosis Burden and Comorbidities in England
A national cohort study in England reveals that rare ichthyosis is linked to higher rates of systemic comorbidities and earlier mortality. The findings suggest that these inherited skin disorders require broader healthcare management than previously recognized.
Why it matters
This research highlights the need for improved clinical management and healthcare planning for patients with rare skin conditions.
RARE ichthyosis was associated with an increased burden of systemic comorbidities and earlier mortality in a national cohort from England, highlighting important implications for healthcare planning and the management of patients with these inherited skin disorders.
Researchers conducted a national retrospective cohort study using routinely collected healthcare data from England between 1998–2024 to characterise the epidemiology of inherited ichthyoses. The study also examined patient level comorbidities, mortality, and genetic testing status. Cases were identified using International Classification of Diseases, Tenth Revision (ICD-10) diagnostic codes, with demographic and clinical information extracted from national healthcare databases.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in